// App-Quantinova.ai

: Identifying predictors of placebo response in osteoarthritis clinical trials of three agents with different routes of delivery: A meta-analysis using individual patient data

Researchers

Presenter

  • J. Stocks

Principal Investigators

  • M.S. Persson

  • M. van Middelkoop

  • J. Runhaar

  • S. Bierma-Zeinstra

  • I. Atchia

  • R. Lambert

  • A.D. Sawitzke

  • T. McAlindon

  • M.H. Hashempur

  • D.A. Walsh

  • M. Doherty

  • W. Zhang

Medical Centers

  • University of Nottingham, Nottingham, United Kingdom

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • University of Alberta, Edmonton, AB, Canada

  • Univ. of Uath, Salt Lake City, UT, USA

  • Fasa Univ. of Med. Sci., Fasa, Islamic Republic of Iran

Locations

  • United Kingdom

  • Netherlands

  • Canada

  • United States

  • Iran

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Body mass index

Drug/Treatment

  • Glucosamine

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

  • Multinational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A